Prospective microbiological study on patients with non-constipation IBS treated with rifaximin 550 mg tablets.
Read time: 1 mins
Last updated:3rd Feb 2011
To determine the effect of Rifaximin 550 mg treatment on the faecal microflora of patients with non-constipation Irritable Bowel Syndrome (non-C IBS).
|Study start date||2011-02-03|